By

Biolog Inc
14
Aug

Discovery of activation of cancer-fighting T cells by inosine, enabled by Biolog metabolic assay technology

Discovery of activation of cancer-fighting T cells by inosine, enabled by Biolog metabolic assay technology Hayward, CA, USA – August 14, 2020 – A multi-site research team headed by Dr. Ruoning Wang at the Nationwide Children’s Hospital has uncovered a metabolic pathway that can potentially be exploited to enhance the killing of anti-cancer T cells...
Read More
13
Feb

ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology

ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology Discovery could open doorway to new treatment Sheffield, UK and Hayward, CA, USA –February 13, 2019–Researchers at the University of Sheffield have identified a new pathway that is disrupted in amyotrophic lateral sclerosis (ALS), a debilitating and ultimately lethal motor neuron disease (MND). The...
Read More
1 2

About Us

Biolog is a world leader in cell-based phenotypic testing technologies and assays. We have focused our efforts on developing technologies and products to test properties of cells (phenotypes) very simply and efficiently.